Miami Clinical Research   Report issue

For profit Phase 1
Founded: Miami FL United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

aluminum hydroxide (Gaviscon) (1 trial)

rf1v vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Plague (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2